These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36586043)

  • 1. Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia.
    Abo-El Fetoh ME; Abdel-Fattah MM; Mohamed WR; Ramadan LAA; Afify H
    Inflammopharmacology; 2023 Feb; 31(1):499-516. PubMed ID: 36586043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probenecid ameliorates testosterone-induced benign prostatic hyperplasia: Implications of PGE-2 on ADAM-17/EGFR/ERK1/2 signaling cascade.
    Abdel-Fattah MM; Abo-El Fetoh ME; Afify H; Ramadan LAA; Mohamed WR
    J Biochem Mol Toxicol; 2023 Nov; 37(11):e23450. PubMed ID: 37352135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common salt aggravated pathology of testosterone-induced benign prostatic hyperplasia in adult male Wistar rat.
    Bello II; Omigbodun A; Morhason-Bello I
    BMC Urol; 2023 Dec; 23(1):207. PubMed ID: 38082261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine prevents the increase of testosterone-induced oxidative stress in a model of rat prostatic hyperplasia.
    Quintero-García M; Delgado-González E; Sánchez-Tusie A; Vázquez M; Aceves C; Anguiano B
    Free Radic Biol Med; 2018 Feb; 115():298-308. PubMed ID: 29248723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcuma oil ameliorates benign prostatic hyperplasia through suppression of the nuclear factor-kappa B signaling pathway in rats.
    Wang S; Li Y; Li W; Zhang K; Yuan Z; Cai Y; Xu K; Zhou J; Du Z
    J Ethnopharmacol; 2021 Oct; 279():113703. PubMed ID: 33340599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional Chinese Medicine Danzhi qing'e decoction inhibits inflammation-associated prostatic hyperplasia via inactivation of ERK1/2 signal pathway.
    Liu Y; Shao R; Suo T; Zhu J; Liu E; Wang Y; Miao L; Gao X
    J Ethnopharmacol; 2023 Jun; 309():116354. PubMed ID: 36906158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectodomain shedding of pro-TGF-alpha is required for COX-2 induction and cell survival in renal medullary cells exposed to osmotic stress.
    Küper C; Bartels H; Fraek ML; Beck FX; Neuhofer W
    Am J Physiol Cell Physiol; 2007 Dec; 293(6):C1971-82. PubMed ID: 17942633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asteris Radix et Rhizoma suppresses testosterone-induced benign prostatic hyperplasia in rats by regulating apoptosis and inflammation.
    Rho J; Seo CS; Park HS; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
    J Ethnopharmacol; 2020 Jun; 255():112779. PubMed ID: 32209388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Febuxostat attenuates testosterone-induced benign prostatic hyperplasia in rats via inhibiting JAK/STAT axis.
    Abo-Youssef AM; Afify H; Azouz AA; Abdel-Rahman HM; Abdel-Naim AB; Allam S
    Life Sci; 2020 Nov; 260():118414. PubMed ID: 32926929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiotensin converting enzyme inhibitor captopril attenuates testosterone-induced benign prostatic hyperplasia in rats; a mechanistic approach.
    Mostafa F; Mantawy EM; Azab SS; El-Demerdash E
    Eur J Pharmacol; 2019 Dec; 865():172729. PubMed ID: 31605676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2.
    Abdel-Aziz AM; Gamal El-Tahawy NF; Salah Abdel Haleem MA; Mohammed MM; Ali AI; Ibrahim YF
    Eur J Pharmacol; 2020 Dec; 889():173631. PubMed ID: 33031799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of Hydrocotyle ramiflora on testosterone-induced benign prostatic hyperplasia in rats.
    Park S; Hwang YH; Baek EB; Hong EJ; Won YS; Kwun HJ
    Int Urol Nephrol; 2023 Jan; 55(1):17-28. PubMed ID: 36107291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia.
    Altavilla D; Minutoli L; Polito F; Irrera N; Arena S; Magno C; Rinaldi M; Burnett BP; Squadrito F; Bitto A
    Br J Pharmacol; 2012 Sep; 167(1):95-108. PubMed ID: 22471974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative.
    Yang X; Yuan L; Xiong C; Yin C; Ruan J
    J Ethnopharmacol; 2014 Nov; 157():105-13. PubMed ID: 25260581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of inflammatory responses, apoptosis, and STAT3/NF-κB- and Nrf2-mediated oxidative stress on benign prostatic hyperplasia induced by a high-fat diet.
    Li Y; Shi B; Dong F; Zhu X; Liu B; Liu Y
    Aging (Albany NY); 2019 Aug; 11(15):5570-5578. PubMed ID: 31412319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulated CFTR During Aging Contributes to Benign Prostatic Hyperplasia.
    Xie C; Sun X; Chen J; Ng CF; Lau KM; Cai Z; Jiang X; Chan HC
    J Cell Physiol; 2015 Aug; 230(8):1906-15. PubMed ID: 25546515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
    Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
    Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB.
    Atawia RT; Mosli HH; Tadros MG; Khalifa AE; Mosli HA; Abdel-Naim AB
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Dec; 387(12):1131-40. PubMed ID: 25164963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl jasmonate reduces testosterone-induced benign prostatic hyperplasia through regulation of inflammatory and apoptotic processes in rats.
    Adaramoye OA; Akanni OO; Abiola OJ; Owumi SE; Akinloye O; Olapade-Olaopa EO
    Biomed Pharmacother; 2017 Nov; 95():1493-1503. PubMed ID: 28946212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins.
    Sayed RH; Saad MA; El-Sahar AE
    Toxicol Appl Pharmacol; 2016 Nov; 311():52-60. PubMed ID: 27687055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.